Kinase Inhibitor Discovery
with an untiring quest for future therapeutics

Carna announces clearance of CTA to initiate clinical trial of AS-1763

Carna announces completion of PMDA review for a clinical trial notification to initiate clinical trial of AS-0141

Financial Results FY2020

Consolidated Financial Results for the Year Ended December 31, 2020

Revision of Results Forecast for the Fiscal Year Ending December 31, 2020

Financial Results FY2020Q3

Consolidated Financial Results for the Third Quarter of the Year Ending December 31, 2020

Financial Results FY2020Q2